Faricimab in DME: Results from phase 3 YOSEMITE and RHINE trials
Caroline Baumal, MD, provides an overview of the efficacy, safety and durability of faricimab in diabetic macular edema (DME) at ASRS 2021.
Caroline Baumal, MD, provides an overview of the efficacy, safety and durability of faricimab in diabetic macular edema (DME) at ASRS 2021. In her presentation, Dr. Baumal highlights results from the Phase 3 YOSEMITE and RHINE trials.
The American Society of Retina Specialists (ASRS) is hosting its 39th Annual Scientific Meeting from October 8-12, 2021, at the JW Marriott San Antonio Hill Country Resort and Spa in San Antonio, Texas.
Related Content: Additional ASRS 2021 Content | Conference Coverage | Ophthalmology
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
